Dexamethasone in Hospitalized Patients with Covid-19

Cited by (1,035)

Items 501–600 of 1,035

1. Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections
   Thierry Gauthier, Wanjun Chen · 2022 · Frontiers in Immunology
2. Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies
   Wen Ma, Songling Tang, Peng Yao, Tingyuan Zhou, Qingsheng Niu, Pei-Fei Liu, Shiyuan Tang, Yao Chen, Lu Gan, Yu Cao · 2025 · Signal Transduction and Targeted Therapy
3. The place for remdesivir in COVID-19 treatment
   Barnaby Edward Young, Thuan Tong Tan, Yee‐Sin Leo · 2020 · The Lancet Infectious Diseases
4. A humanized mouse model of chronic COVID-19
   Esen Sefik, Benjamin Israelow, Haris Mirza, Jun Zhao, Rihao Qu, Eleanna Kaffe, Eric Song, Stephanie Halene, Eric Meffre, Yuval Kluger et al. · 2021 · Nature Biotechnology
5. Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
   Donna R. R Rivera, Solange Peters, Orestis A. Panagiotou, Dimpy P. Shah, Nicole M. Kuderer, Chih–Yuan Hsu, Samuel M. Rubinstein, Brendan J. Lee, Toni K. Choueiri, Gilberto De Lima Lopes Jr. et al. · 2020 · Cancer Discovery
6. Clinical features and prognostic factors in Covid-19: A prospective cohort study
   Sanne de Bruin, Lieuwe D. J. Bos, Marian A. van ROON, Anita M. Tuip‐de Boer, Alex R. Schuurman, Marleen J.A. Koel-Simmelinck, Harm Jan Bogaard, Pieter Roel Tuinman, Michiel A. van Agtmael, Jörg Hamann et al. · 2021 · EBioMedicine
7. Randomised clinical trials in critical care: past, present and future
   Anders Granholm, Waleed A. Alhazzani, Lennie P. G. Derde, Derek C. Angus, Fernando Godinho Zampieri, Naomi E. Hammond, Rob Mac Sweeney, Sheila Nainan Myatra, Élie Azoulay, Kathy Rowan et al. · 2021 · Intensive Care Medicine
8. Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021
   Jennifer L. Wiltz, Amy K. Feehan, Noelle‐Angelique Molinari, Chandresh Nanji Ladva, Benedict I. Truman, Jeffrey E. Hall, Jason P. Block, Sonja A. Rasmussen, Joshua Lee Denson, William E. Trick et al. · 2022 · MMWR Morbidity and Mortality Weekly Report
9. Postoperative systemic inflammatory dysregulation and corticosteroids: a narrative review
   Chris Bain, Paul Stewart Myles, Tomas B. Corcoran, Jan M. Dieleman · 2022 · Anaesthesia
10. Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients
    Simon Feys, Agostinho Carvalho, Cornelius Joseph Clancy, Jean‐Pierre Gangneux, Martin Hoenigl, Katrien Lagrou, Bart J. A. Rijnders, Laura Seldeslachts, Lore Vanderbeke, Frank L. van de Veerdonk et al. · 2024 · The Lancet Respiratory Medicine
11. COVID-19: In the Eye of the Cytokine Storm
    Roberto de la Rica, Marcío Borges-Sa, Marta González‐Freire · 2020 · Frontiers in Immunology
12. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation
    Antoine Beurnier, Etienne‐Marie Jutant, Mitja Jevnikar, Athénaïs Boucly, Jérémie Pichon, Mariana Preda, Marie Frank, Jeremy Laurent, Christian Richard, Xavier Monnet et al. · 2020 · European Respiratory Journal
13. COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae
    Leonardo Italia, Daniela Tomasoni, Stefano Bisegna, Edoardo Pancaldi, Lorenzo Stretti, Marianna Adamo, Marco Metra · 2021 · Frontiers in Cardiovascular Medicine
14. SARS-CoV-2 in immunocompromised individuals
    Susan DeWolf, Justin C. Laracy, Miguel‐Angel Perales, Mini Kamboj, Marcel R.M. van den Brink, Santosha Adipudi Vardhana · 2022 · Immunity
15. COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development
    M Sreepadmanabh, Amit Kumar Sahu, Ajit G. Chande · 2020 · Journal of Biosciences
16. Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020
    Charlotte Kaeuffer, Coralie Le Hyaric, Thibaut Fabacher, Joy Mootien, Benjamin Dervieux, Yvon Ruch, Antonin Hugerot, Yves-Jean Zhu, Valentin Pointurier, Raphaël Clère-Jehl et al. · 2020 · Eurosurveillance
17. Major differences in ICU admissions during the first and second COVID-19 wave in Germany
    Christian Karagiannidis, Wolfram Windisch, Daniel Francis McAuley, Tobias Welte, Reinhard Busse · 2021 · The Lancet Respiratory Medicine
18. Phagocytosis, Degranulation and Extracellular Traps Release by Neutrophils—The Current Knowledge, Pharmacological Modulation and Future Prospects
    B. Gierlikowska, A. Stachura, W. Gierlikowski, U. Demkow · 2021 · Frontiers in Pharmacology
19. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response
    Yongzhen Liu, Chao Qin, Youliang Rao, Chau Ngo, Joshua J. Feng, Jun Zhao, Shu Jie Zhang, Tingyu Wang, Jessica Carrière, Ali Can Savas et al. · 2021 · mBio
20. Bacterial and fungal superinfections in critically ill patients with COVID-19
    Matteo Bassetti, Marin H. Kollef, JF Timsit · 2020 · Intensive Care Medicine
21. Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2–related Disease
    Mayte Suárez‐Fariñas, Minami A. Tokuyama, Gabrielle Wei, Ruiqi Huang, Alexandra E. Livanos, Divya Jha, Anaïs Levescot, Haritz Irizar, Roman Kosoy, Sascha Cording et al. · 2020 · Gastroenterology
22. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study
    Nathan James Brendish, Stephen Poole, Vasanth V Naidu, Christopher Mansbridge, Nicholas Norton, Helen Wheeler, Laura Presland, Stephen P. Kidd, Nicholas Cortes, Florina Borca et al. · 2020 · The Lancet Respiratory Medicine
23. The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19
    Jingjing Cai, Haomiao Li, Changjiang Zhang, Ze Chen, Hui Liu, Fang Lei, Juan-Juan Qin, Ye-Mao Liu, Feng Zhou, Xiaohui Song et al. · 2021 · Cell Metabolism
24. Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region
    Gauthier Blonz, Achille Kouatchet, Nicolas Chudeau, Emmanuel Pontis, Julien Lorber, Anthony Lemeur, Lucie Planche, Jean-Baptiste Lascarrou, Gwenhaël Colin · 2021 · Critical Care
25. Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review
    Mohammad Said Ramadan, Lorenzo Bertolino, Rosa Zampino, Emanuele Durante‐Mangoni, Emanuele Durante‐Mangoni, Domenico Iossa, Lorenzo Bertolino, Maria Paola Ursi, Fabiana D’Amico, Arta Karruli et al. · 2021 · Clinical Microbiology and Infection
26. Chronic hepatitis E: Advancing research and patient care
    Zhongren Ma, Robert Auke de Man, Nassim Kamar, Qiuwei Pan · 2022 · Journal of Hepatology
27. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
    Obbina Abani, Ali H. Abbas, Fatima Abbas, Joshua Abbas, Kasim Abbas, Mustafa A. Abbas, Sadia Abbasi, Hakam Abbass, Alfie Abbott, Alison Abbott et al. · 2023 · The Lancet
28. T cell immunobiology and cytokine storm of COVID‐19
    Xiao-Hua Luo, Yan Zhu, Jian Mao, R. Du · 2020 · Scandinavian Journal of Immunology
29. Impact of Heart Failure on the Clinical Course and Outcomes of Patients Hospitalized for COVID-19. Results of the Cardio-COVID-Italy Multicentre Study
    Daniela Tomasoni, Riccardo Maria Inciardi, Carlo Lombardi, Chiara Tedino, Piergiuseppe Agostoni, Pietro Ameri, Lucia Barbieri, Antonio Bellasi, Rita Camporotondo, Claudia Canale et al. · 2020 · European Journal of Heart Failure
30. Gastrointestinal manifestations in COVID-19
    Jayani Kariyawasam, Umesh Jayarajah, Rishdha Riza, Visula Abeysuriya, Suranjith Luke Seneviratne · 2021 · Transactions of the Royal Society of Tropical Medicine and Hygiene
31. Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient – Case report and review of literature
    Akshay M Khatri, Kai-Ming Chang, Ilan Berlinrut, Frances R. Wallach · 2021 · Journal de Mycologie Médicale
32. Combating Oxidative Stress and Inflammation in COVID‐19 by Molecular Hydrogen Therapy: Mechanisms and Perspectives
    Duried Alwazeer, Franky Fuh-Ching Liu, Xiao Yu Wu, Tyler W. LeBaron · 2021 · Oxidative Medicine and Cellular Longevity
33. Disulfiram inhibits neutrophil extracellular trap formation and protects rodents from acute lung injury and SARS-CoV-2 infection
    José M. Adrover, Lucía Carrau, Juliane Daßler‐Plenker, Yaron Bram, Vasuretha Chandar, Sean Houghton, David Redmond, Joseph R. Merrill, Margaret E. Shevik, Benjamin Robert tenOever et al. · 2022 · JCI Insight
34. Characteristics of candidemia in COVID‐19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non‐COVID‐19 patients
    Kayaaslan, Bircan, Eser, Fatma, Kaya Kalem, Ayşe, Bilgic, Zeynep, Asilturk, Dilek, Hasanoglu, Imran, Ayhan, Muge, Tezer Tekce, Yasemin, Erdem, Deniz, Turan, Sema et al. · 2021 · Mycoses
35. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
    Sumanth Khadke, Nayla Ahmed, Nausheen Ahmed, Ryan Ratts, Shine Raju, Molly Megan Gallogly, Marcos J. G. De Lima, Muhammad Rizwan Sohail · 2020 · Virology Journal
36. Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)
    Chunxue Bai, Sanjay Haresh Chotirmall, Jordi Rello, George A. Alba, Leo C. Ginns, Jerry A. Krishnan, Robert Rogers, Elisabeth M. Bendstrup, Pierre‐Régis Burgel, James Duncan Chalmers et al. · 2020 · European Respiratory Review
37. Epidemiological and Clinical Characteristics of COVID-19 in Children: A Systematic Review and Meta-Analysis
    Bingbing Li, Shan Zhang, Ruili Zhang, Xi Chen, Yong Wang, Changlian Zhu · 2020 · Frontiers in Pediatrics
38. The Impact of COVID-19 Viral Infection on the Hypothalamic-Pituitary-Adrenal Axis
    Ali Saeed Alzahrani, Noha N Mukhtar, Abeer Aljomaiah, Hadeel Salah Aljamei, ABDULMOHSEN M.K. BAKHSH, Nada Alsudani, Tarek Elsayed, Nahlah Alrashidi, Roqayh Fadel, Eman Alqahtani et al. · 2020 · Endocrine Practice
39. Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research
    Vibhu Paudyal, Shusen Sun, Rabia Hussain, Mohammed Abutaleb, Erick Wesley Hedima · 2021 · Research in Social and Administrative Pharmacy
40. Effects of Remdesivir in Hospitalized Patients with COVID-19: Systematic Review and Individual Patient Data Meta-Analysis of Randomized Clinical Trials
    Alain Amstutz, Benjamin Speich, France Mentré, Corina S. Rueegg, Drifa Belhadi, Lambert Assoumou, Charles Burdet, Srinivas Murthy, Lori Elizabeth Dodd, Yeming Wang et al. · 2022 · The Lancet Respiratory Medicine
41. Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
    the RCI-COVID-19 Study Group, Kooistra, Emma J., Waalders, Nicole J. B., Grondman, Inge, Janssen, Nico A. F., de Nooijer, Aline H., Netea, Mihai G., van de Veerdonk, Frank L., Ewalds, Esther, van der Hoeven, Johannes G. et al. · 2020 · Critical Care
42. COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment – A narrative review
    Carmen Andrea Pfortmueller, Thibaud Spinetti, Richard D. Urman, Markus Martin Luedi, Joerg C. Schefold · 2020 · Best practice & research. Clinical anaesthesiology
43. Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell
    Serge Daniel Le Bon, Déborah Konopnicki, Nathalie Pisarski, Léa Prunier, Jerome Rene Lechien, Mihaéla Horoi · 2021 · European Archives of Oto-Rhino-Laryngology
44. Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells
    Dingxi Zhou, Mariana Borsa, Anna Katharina Simon · 2021 · Aging Cell
45. COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors
    Joshua Elliott, Barbara Bodinier, Matthew D. Whitaker, Cyrille Delpierre, Roel C.H. Vermeulen, Ioanna Tzoulaki, Paul Elliott, Marc Chadeau‐Hyam · 2021 · European Journal of Epidemiology
46. Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19
    Raymund Rabe Razonable, Colin Pawlowski, John Charles O’Horo, Lori L. Arndt, Richard F. Arndt, Dennis M. Bierle, Molly J. Destro Borgen, Sara N. Hanson, Michelle C. Hedin, Patrick J. Lenehan et al. · 2021 · EClinicalMedicine
47. Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave
    Fleur H.J. Kaptein, Milou A.M. Stals, M. Grootenboers, Sander J.E. Braken, Johanna Louise I. Burggraaf, Bas C. T. van Bussel, Suzanne C. Cannegieter, Hugo Ten Cate, Henrik Endeman, Diederik A M P J Gommers et al. · 2020 · Thrombosis Research
48. A review of potential suggested drugs for coronavirus disease (COVID-19) treatment
    Parastoo Tarighi, Samane Eftekhari, Milad Chizari, Mahsa Sabernavaei, Davod Jafari, Parastoo Mirzabeigi · 2021 · European Journal of Pharmacology
49. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients
    Samantha M. Morrissey, Anne E. Geller, Xiaoling Hu, David A. Tieri, Chuanlin Ding, Christopher K. Klaes, Elizabeth A. Cooke, Matthew R. Woeste, Zachary C. Martin, Oscar Chen et al. · 2021 · JCI Insight
50. Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgent
    Trisha Greenhalgh, David N. Fisman, Danielle J. Cane, Matthew Oliver, Chandini Raina MacIntyre · 2022 · BMJ Evidence-Based Medicine
51. Impact of COVID-19 on Cardiovascular Disease
    Ivan Vosko, Andreas Zirlik, Heiko Bugger · 2023 · Viruses
52. Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal
    Mohammad Sultan Khuroo · 2020 · International Journal of Antimicrobial Agents
53. The role of Interleukin 6 inhibitors in therapy of severe COVID-19
    Evgeny Lvovich Nasonov, Samsonov MIu · 2020 · Biomedicine & Pharmacotherapy
54. Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19
    Hanny T. Al-Samkari, Shruti Gupta, Rebecca Karp Leaf, Wei Wang, Rachel Pam Greenerger Rosovsky, Samantha K. Brenner, Salim S. Hayek, Hanna P. Berlin, Rajat Kapoor, Shahzad Shaefi et al. · 2021 · Annals of Internal Medicine
55. Second versus first wave of COVID-19 deaths: Shifts in age distribution and in nursing home fatalities
    John P. A. Ioannidis, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis · 2021 · Environmental Research
56. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications
    Saamia Faruqui, Fidelis C. Okoli, Sonja K. Olsen, David M. Feldman, Harmit S. Kalia, James S Park, Carmen M. Stanca, Viviana Figueroa Diaz, Sarah Yuan, Nabil N. Dagher et al. · 2021 · The American Journal of Gastroenterology
57. Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19
    José Ramón Arribas, Sanjay R. Bhagani, Suzana M. Lobo, Хаертынова Ильсияр Мансуровна, Lourdes Mateu, Roman Fishchuk, William Y. Park, Khetam Hussein, Sei Won Kim, Jade Ghosn et al. · 2021 · NEJM Evidence
58. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
    Edward Burn, Seng Chan You, Anthony G. Sena, Kristin Kostka, Hamed Abedtash, Maria Tereza Fernandes Abrahão, Amanda Alberga, Heba Alghoul, Osaid H. Alser, Thamir M. Alshammari et al. · 2020 · Nature Communications
59. Therapy for Early COVID-19
    Peter S. Kim, Sarah W. Read, Anthony S. Fauci · 2020 · JAMA
60. The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19
    Philip Cameron Robinson, David F. L. Liew, Jean W. Liew, Claudia Gianini Monaco, Duncan B. Richards, Senthuran Shivakumar, Helen L. Tanner, Marc Feldmann · 2020 · Med
61. Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial
    Xiaowei Xu, Wanli Jiang, Lijun Chen, Zhenyu Xu, Qiang Zhang, Mengfei Zhu, Peng Ye, Hang Li, Liang Yu, Xiaoyang Zhou et al. · 2021 · Clinical and Translational Medicine
62. Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis
    Anthony Paulo Sunjaya, Sabine M. Allida, Gian Luca Di Tanna, Christine R. Jenkins · 2021 · Journal of Asthma
63. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
    Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson, Carlos A. Gómez, Vincent C. Marconi, Mamta K. Jain, Otto O. Yang, Catharine I. Paules, Guillermo M. Ruiz Palacios, Robert M Grossberg et al. · 2022 · The Lancet Respiratory Medicine
64. Pros and cons of corticosteroid therapy for COVID-19 patients
    Paula Mattos-Silva, Nathane Santanna Felix, Pedro Leme Silva, Chiara Robba, Denise Battaglini, Paolo P. Pelosi, Patrícia R. M. Rocco, Fernanda Ferreira Cruz · 2020 · Respiratory Physiology & Neurobiology
65. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
    Jesús Rodríguez‐Baño, Jerónimo Pachón, Jordi Carratalà, Pablo Ryan, Inmaculada Jarrín, María Yllescas, José Ramón Arribas, Juan Berenguer, Esther Aznar Muñoz, Pedro Gil Divasson et al. · 2020 · Clinical Microbiology and Infection
66. The COVID-19 pandemic: consequences for nephrology
    Annette N. Bruchfeld · 2020 · Nature Reviews Nephrology
67. Intensive care management of patients with COVID-19: a practical approach
    Ludhmila Abrahão Hajjar, Isabela Bispo Santos da Silva Costa, Stéphanie Itala Rizk, Bruno Biselli, Brenno Rizerio Gomes, Cristina Salvadori Bittar, Gisele Queiroz de Oliveira, Juliano Pinheiro de Almeida, Mariana Vieira de Oliveira Bello, Cibele Larrosa Garzillo et al. · 2021 · Annals of Intensive Care
68. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19
    Rainer W. J. Kaiser, Alexander Leunig, Kami Pekayvaz, Oliver Popp, Markus Joppich, Vivien Polewka, Raphael Escaig, Afra Anjum, Marie‐Louise Hoffknecht, Christoph Gold et al. · 2021 · JCI Insight
69. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2
    Catherine F. Hatton, Rachel Anne Botting, María Emilia Dueñas, Iram Haq, Bernard Verdon, Benjamin J. Thompson, Jarmila Stremenova Spegarova, Florian Gothe, Emily Stephenson, Aaron Ions Gardner et al. · 2021 · Nature Communications
70. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
    Jasimuddin Ahamed, Jeffrey C. Laurence · 2022 · Journal of Clinical Investigation
71. Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies
    Gihanna Galindez, Julian Matschinske, Tim Daniel Rose, Sepideh Sadegh, Marisol Salgado-Albarrán, Julian Späth, Jan Baumbach, Josch Konstantin Pauling · 2021 · Nature Computational Science
72. Neutralizing Antibody Therapeutics for COVID-19
    A. Hurt, A. Wheatley · 2021 · Viruses
73. Mesenchymal stem cell therapy for severe COVID-19
    Lei Shi, Lifeng Wang, Ruonan Xu, Chao Zhang, Yunbo Xie, Kai Liu, Tiantian Li, Wei Hu, Cheng Zhen, Fu‐Sheng Wang · 2021 · Signal Transduction and Targeted Therapy
74. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
    Andrea Becerril‐Gaitan, Bryan F. Vaca‐Cartagena, Ana S. Ferrigno, Fernanda Mesa-Chávez, Tonatiuh Barrientos‐Gutiérrez, Marco Tagliamento, Matteo Lambertini, Cynthia Mayte Villarreal-Garza · 2021 · European Journal of Cancer
75. Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial
    Marie Warrer Munch, Sheila Ninan Myatra, Bharath Kumar Tirupakuzhi Vijayaraghavan, Sanjith Saseedharan, Thomas Benfield, Rebecka Rubenson Wahlin, Bodil Steen Rasmussen, Anne Sofie Andreasen, Lone Musaeus Poulsen, Luca Cioccari et al. · 2021 · Intensive Care Medicine
76. Efficacy of Remdesivir in COVID-19
    Erin K McCreary, Derek Angus · 2020 · JAMA
77. After 62 years of regulating immunity, dexamethasone meets COVID-19
    Derek W. Cain, John Anthony Cidlowski · 2020 · Nature reviews. Immunology
78. Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants
    Lucy Catteau, Nicolás Dauby, Marion Montourcy, Emmanuel Bottieau, Joris Hautekiet, Els J. T. Goetghebeur, Sabrina H. van Ierssel, Els Duysburgh, Herman J. Van Oyen, Chloé Wyndham-Thomas et al. · 2020 · International Journal of Antimicrobial Agents
79. Protein kinases: drug targets for immunological disorders
    Leslie A. Castelo‐Soccio, Hanna Kim, Massimo Gadina, Pamela L. Schwartzberg, Arian D. J. Laurence, John J. O’Shea · 2023 · Nature reviews. Immunology
80. Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations
    John P. A. Ioannidis · 2021 · European Journal of Clinical Investigation
81. Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
    Jurjan Aman, Erik Duijvelaar, Liza Botros, Azar Kianzad, Job R. Schippers, Patrick J. Smeele, Sara Azhang, Imke Heleen Bartelink, Ahmed Abdallah Bayoumy, Pierre M. Bet et al. · 2021 · The Lancet Respiratory Medicine
82. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)
    Simone Cesaro, Per T Ljungman, Małgorzata Mikulska, Hans Hellmuth Hirsch, Marie von Lilienfeld‐Toal, Catherine Cordonnier, Sylvain Meylan, Varun Mehra, Jan Styczyński, Francesco Marchesi et al. · 2022 · Leukemia
83. Targeting the host response in sepsis: current approaches and future evidence
    Christian Bode, Sebastian Weis, Andrea Sauer, Pedro David Wendel‐Garcia, Sascha David · 2023 · Critical Care
84. Immune cartography of macrophage activation syndrome in the COVID-19 era
    Dennis McGonagle, Athimalaipet Vaidyanathan Ramanan, Charlie Bridgewood · 2021 · Nature Reviews Rheumatology
85. Discovering symptom patterns of COVID-19 patients using association rule mining
    Meera Tandan, Yogesh Acharya, Suresh Pokharel, Mohan Timilsina · 2021 · Computers in Biology and Medicine
86. Respiratory viral infections in the elderly
    Alastair Watson, Tom M. A. Wilkinson · 2021 · Therapeutic Advances in Respiratory Disease
87. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells
    Ruben Manuel Luciano Colunga Biancatelli, Pavel A. Solopov, Elizabeth R. Sharlow, John Stephen Lazo, Paul Ellis Marik, John D. Catravas · 2021 · American Journal of Physiology-Lung Cellular and Molecular Physiology
88. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
    Yuwen Zhou, Yao Xie, Liansha Tang, Dan Pu, Yajuan Zhu, Jiyan Liu, Xuelei Ma · 2021 · Signal Transduction and Targeted Therapy
89. Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort
    Essy Mozaffari, Aastha N. Chandak, Zhiji Zhang, Shuting Liang, Mark W. Thrun, Robert Gottlieb, Daniel R. Kuritzkes, Paul Edward Sax, David Alain Wohl, Roman Casciano et al. · 2021 · Clinical Infectious Diseases
90. Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
    Rajendra Karki, Thirumala‐Devi Kanneganti · 2022 · Journal of Translational Medicine
91. Immunosuppressive Drugs and COVID-19: A Review
    Tessa S Schoot, Angèle P. M. Kerckhoffs, Luuk B. Hilbrands, Rob J. van Marum · 2020 · Frontiers in Pharmacology
92. Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
    Nur Zawanah Zabidi, Hern Liang Liew, Isra Ahmad Farouk, Ashwini Puniyamurti, Ashley Jia Wen Yip, Vindya Nilakshi Wijesinghe, Zheng Yao Low, Julian Wei-Tze Tang, Vincent T. K. Chow, Sunil Kumar Lal · 2023 · Viruses
93. High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
    David Schub, Verena Klemis, Sophie Schneitler, Janine Mihm, Philipp Moritz Lepper, Heinrike Wilkens, Robert Bals, Hermann Eichler, Barbara Christine Gärtner, Sören L. Becker et al. · 2020 · JCI Insight
94. Botanical drugs and supplements affecting the immune response in the time of COVID ‐19: Implications for research and clinical practice
    Thomas Brendler, Ahmed Al‐Harrasi, Rudolf Bauer, Stefan Gafner, Mary L Hardy, Michael Heinrich, Hossein Hosseinzadeh, Angelo Antonio Izzo, Martin Michaelis, Marjan Nassiri‐Asl et al. · 2020 · Phytotherapy Research
95. Blood DNA methylation and COVID-19 outcomes
    Joseph Balnis, Andy Madrid, Kirk J. Hogan, Lisa A. Drake, Hau Chieng, Anupama Tiwari, Catherine E. Vincent, Amit Chopra, Peter A. Vincent, Michael D. Robek et al. · 2021 · Clinical Epigenetics
96. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19
    Michael Ohl, Donald R. Miller, Brian C. Lund, Takaaki Kobayashi, Kelly Richardson Miell, Brice F. Beck, BRUCE K. ALEXANDER, Kristina A. Crothers, Mary Vaughan‐Sarrazin · 2021 · JAMA Network Open
97. Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?
    Niraj Konchady Shenoy, Rebecca A. Luchtel, Perminder Gulani · 2020 · BMC Medicine
98. Asthma and COVID-19: an update
    Yochai Adir, Walid Saliba, Antoine Beurnier, Marc J.C. Humbert · 2021 · European Respiratory Review
99. Single-cell immunology of SARS-CoV-2 infection
    Yuan Tian, Lindsay N. Carpp, Helen E. R. Miller, Michael A. Zager, Evan William Newell, Raphaël Gottardo · 2021 · Nature Biotechnology
100. Small molecules in the treatment of COVID-19
     Sibei Lei, Xiaohua Chen, Jieping Wu, Xingmei Duan, Ke Men · 2022 · Signal Transduction and Targeted Therapy